Cell and gene therapy (CGT) is an advanced biopharmaceutical, requiring highly reproducible and reliable manufacturing processes to ensure effective product development.

CellabMED's CGT Center is a GMP manufacturing facility in Korea University's Medical Science Park. The professional staff ensure production of the highest quality investigational products based on CAR-T cell therapy production and analysis technology gleaned from years of experience.

CGT Center

• 

  is located at the Hongneung InnoTown linked to Korea University, Korea Institute of Science and Technology (KIST) and Seoul Bio Hub

• 

  is designed and constructed as a GMP manufacturing facility by dividing it into 3 zones (approx. 661 ㎡)

• 

  has a Quality Analysis Lab that performs sterility testing, adventitious virus testing and mycoplasma detection testing

• 

  achieves smooth process development by closely collaborating with the research center in the same building

• 

  CGT Center, of CellabMED is equipped with hardware and software to provide stable samples, accelerate new drug development, conduct optimized production processes, and meet GMP standards while closely collaborating with other institutions.